Bipolar disorder and dopamine dysfunction: An indirect approach focusing on tardive movement syndromes in a naturalistic setting

BMC Psychiatry

Volumn 9, Issue , 2009, Pages

  van Rossum, Inge ^a   Tenback, Diederik ^b,c   van Os, Jim ^d,e  

^a Eli Lilly and Company   (Netherlands)

^b Symfora Group   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LITHIUM SALT; NEUROLEPTIC AGENT; PROLACTIN; PSYCHOTROPIC AGENT;

ADULT; AMENORRHEA; ARTICLE; BIPOLAR DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; TARDIVE DYSKINESIA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DYSKINESIA; EXTRAPYRAMIDAL SYNDROME; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; DOPAMINE; DYSKINESIA, DRUG-INDUCED; DYSKINESIAS; DYSTONIA; FEMALE; HUMANS; INCIDENCE; MALE; PROLACTIN; PSYCHOTROPIC DRUGS;

EID: 66049115810     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-9-16     Document Type: Article

References (34)

1. Cavazzoni PA Berg PH Kryzhanovskaya LA Briggs SD Roddy TE Tohen M Kane JM Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania and schizophrenia during olanzapine clinical trials J Clin Psychiatry 2006, 67:107-113 16426096
2. Keck PE McElroy SL Strakowski SM Soutullo CA Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia J Clin Psychiatry 2000, 61(suppl 4):33-38 10739329
3. Berk M Dodd S Kauer-Sant'anna M Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder Acta Psychiatr Scand 2007, 434(suppl):41-49 10.1111/j.1600-0447.2007.01058.x
4. Tenback DE van Harten PN Slooff CJ van Os J SOHO Study Group Tardive dyskinesia in schizophrenia is associated with prolactin-related side effects Neuropsychopharmacology 2006, 31:1832-1837 10.1038/ sj.npp.1301044 16482082
5. Stahl SM Stahl's essential psychopharmacology Cambridge: Cambridge University Press 2008
6. Tenback DE van Harten PN Slooff CJ van Os J SOHO Study Group Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatients Health Outcomes study Comprehensive Psychiatry 2007, 48:436-440 10.1016/ j.comppsych.2007.05.003 17707251
7. Diehl DJ Gershon S The role of dopamine in mood disorders Compr Psychiatry 1992, 33(2):115-120 10.1016/0010-440X(92)90007-D 1347497
8. Dunlop BW Nemeroff CB The role of dopamine in the pathophysiology of depression Arch Gen Psychiatry 2007:327-337 10.1001/archpsyc.64.3.327 17339521
9. Tenback DE van Harten PN Slooff CJ van Os J SOHO Study Group Evidence that early extrapyramidal symptoms predict later tardive dyskinesia Am J Psychiatry 2006, 163:1438-1440 10.1176/appi.ajp.163.8.1438 16877660
10. Goetz I Tohen M Reed C Lorenzo M Vieta E the EMBLEM Advisory Board Functional impairment in patients with mania: Baseline results of the EMBLEM study Bipolar Disord 2007, 9(1-2):45-52 10.1111/ j.1399-5618.2007.00325.x 17391349
11. Haro JM Van Os J Vieta E Reed C Lorenzo M Goetz I the EMBLEM Advisory Board Evidence for Three Distinct Classes of 'Typical', 'Psychotic' and 'Dual' Mania: Results from the EMBLEM study Acta Psychiatr Scand 2006, 113(2):112-120 10.1111/j.1600-0447.2005.00692.x 16423162
12. Van Harten PN Hoek HW Matroos GE Koeter M Kahn R Inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: The Curaçao extrapyramidal symdromes study II Schizophr Res 1996:235-242 8794515
13. Van Harten PN Hoek HW Matroos GE Van Os J Incidence of tardive dyskinesia and tardive dystonia in African Carribean patients on long-term antipsychotic treatment: The Curacao extrapyramidal syndromes study V J Clin Psychiatry 2006, 67:1920-1927 17194270
14. Burke RE Kang UJ Tardive dystonia: Clinical aspects and treatment Adv Neurol 1988, 49:199-210 3278541
15. Sachdev P Risk factors for tardive dystonia: A case-control comparison with tardive dyskinesia Acta Psychiatr Scand 1993, 88(2):98-103 10.1111/ j.1600-0447.1993.tb03421.x 8105638
16. Chouinard G Margolese HC Manual for the Extrapyramidal Symptom Rating Scale (ESRS) Schizophr Res 2005, 76(2-3):247-265 10.1016/ j.schres.2005.02.013 15949657
17. Guy WA Abnormal Involuntary Movement Scale (AIMS) Washington, U.S. Department of Health Education and Welfare, Washington DC 1976:534-537
18. Spearing MK Post RM Leverich GS Modification of the Clinical Global Impressions (CGI) Scale for Use in Bipolar Illness (BP): The CGI-BP Psychiatry Res 1997, 73:159-171 10.1016/S0165-1781(97)00123-6 9481807
19. Knegtering H Moolen van der AE Castelein S Kluiter H Bosch van den RJ What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 2003, 28:109-123 10.1016/ S0306-4530(02)00130-0 12650685
20. Knegtering H Bosch van den R Castelein S Bruggeman R Sytema S van Os J Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology 2008, 33:711-717 10.1016/ j.psyneuen.2008.02.008 18395353
21. Correll CU Leucht S Kane JM Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies Am J Psychiatry 2004, 161(3):414-425 10.1176/appi.ajp.161.3.414 14992963
22. Van Os J Fahy T Jones P Harvey I Toone B Murray R Tardive dyskinesia: who is at risk? Acta Psychiatr Scand 1997, 96(3):206-216 10.1111/ j.1600-0447.1997.tb10153.x 9296552
23. Van Os J Walsh E Van Horn E Tattan T Bale R Thompson SG Tardive dyskinesia in psychosis: Are women really more at risk? UK700 Group Acta Psychiatr Scand 1999, 99(4):288-293 10.1111/j.1600-0447.1999.tb07227.x 10223432
24. Hunt N Silverstone T Tardive dyskinesia in bipolar affective disorder: A catchment study Int Clin Psychopharmacol 1991, 6:45-50 10.1097/ 00004850-199100610-00006 1677020
25. Casey DE Tardive dyskinesia and atypical antipsychotic drugs Schiz Res 1999, 35:S61-66 10.1016/S0920-9964(98)00160-1
26. Waddington JL Brown K O'Neill J McKeon P Kinsella A Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: Relationship to tardive dyskinesia Psychol Med 1989, 19(4):897-902 2574475
27. Joffe MM Rosenbaum PR Invited commentary: Propensity scores Am J Epidemiol 1990, 150(4):327-333
28. Klungel OH Martens EP Psaty BM Grobbee DE Sullivan SD Stricker BH Leufkens HG de Boer A Methods to assess intended effects of drug treatment in observational studies are reviewed J Clin Epidemiology 2004, 57:1223-1231 10.1016/j.jclinepi.2004.03.011
29. STATACORP Stata Statistical Software: Release 10.0 TXS: Stata Corporation: College Station TX 2008
30. Van Harten PN Martoos GE Hoek HW Kahn RS The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia Schiz Res 1996, 19:195-203 10.1016/0920-9964(95)00096-8
31. Van Harten PN Kahn RS Tardive dystonia Schiz Bull 1999, 25(4):741-748
32. Moncrieff J Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse Acta Psych Scand 2006, 114:3-13 10.1111/ j.1600-0447.2006.00787.x
33. Chouinard G Annable L Ross-Chouinard A Supersensitivity psychosis and tardive dyskinesia: A survey in schizophrenic outpatients Psychopharmacol Bull 1986, 22(3):891-896 2879310
34. Nasrallah H Focus on lower risk of tardive dyskinesia with atypical antipsychotics Annals of Clinical Psychiatry 2006, 18:57-62 10.1080/ 10401230500464737 16517454